GentleLake Posted September 20, 2018 Report Share Posted September 20, 2018 https://www.fda.gov/AnimalVeterinary/NewsEvents/CVMUpdates/ucm620934.htm FDA NOTICE POSTED 9/20/18 ON BRAVECTO, NEXGARD, SIMPARICA (potentially Credelio too) and adverse events such as muscle tremors, ataxia, and seizures. "The U.S. Food and Drug Administration is alerting pet owners and veterinarians to be aware of the potential for neurologic adverse events in dogs and cats when treated with drugs that are in the isoxazoline class. Since these products have obtained their respective FDA approvals, data received by the agency as part of its routine post-marketing activities indicates that some animals receiving Bravecto, Nexgard or Simparica have experienced adverse events such as muscle tremors, ataxia, and seizures. Another product in this class, Credelio, recently received FDA approval. These products are approved for the treatment and prevention of flea infestations, and the treatment and control of tick infestations." Quote Link to comment Share on other sites More sharing options...
gcv-border Posted September 20, 2018 Report Share Posted September 20, 2018 Quote Thanks for the heads up. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.